Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity

Back to the Future: Mismatched Unrelated Donor, Haploidentical Related Donor, or Unrelated Umbilical Cord Blood Transplantation?

(2012) Claudio Anasetti et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells

(2012) S. Gill et al.   BLOOD

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

(2012) Natalia Lapteva et al.   CYTOTHERAPY

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

(2012) T. K. Garg et al.   HAEMATOLOGICA

The role of natural killer cells in immunity against multiple myeloma

(2012) James Godfrey et al.   LEUKEMIA & LYMPHOMA

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

(2012) Cecele J. Denman et al.   PLoS One

Role of Killer Immunoglobulin-like Receptor–Ligand Interactions in Human Leukocyte Antigen–Matched Sibling Hematopoietic Stem Cell Transplantation

(2012) U. Kanga et al.   TRANSPLANTATION PROCEEDINGS

Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells

(2011) Eirini Katodritou et al.   AMERICAN JOURNAL OF HEMATOLOGY

Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma

(2011) L. Giaccone et al.   BLOOD

Milestones in umbilical cord blood transplantation

(2011) Eliane Gluckman et al.   BRITISH JOURNAL OF HAEMATOLOGY

Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up

(2011) Bo Björkstrand et al.   JOURNAL OF CLINICAL ONCOLOGY

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

(2011) Amrita Krishnan et al.   LANCET ONCOLOGY

Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

(2011) N Kröger et al.   LEUKEMIA

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process

(2011) Jan Spanholtz et al.   PLoS One

Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?

(2010) Roel Willemze et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion

(2010) Dongxia Xing et al.   JOURNAL OF IMMUNOTHERAPY

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

(2010) V Hoyos et al.   LEUKEMIA

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy

(2010) Jan Spanholtz et al.   PLoS One

The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor Cells

(2009) Rose C. Beck et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity

(2009) C. G. Brunstein et al.   BLOOD

Human-Like Mouse Models for Testing the Efficacy and Safety of Anti- 2-Microglobulin Monoclonal Antibodies to Treat Myeloma

(2009) J. Yang et al.   CLINICAL CANCER RESEARCH

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma

(2009) Jean-Luc Harousseau et al.   NEW ENGLAND JOURNAL OF MEDICINE

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

(2008) L. Rosinol et al.   BLOOD

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

(2008) E. Alici et al.   BLOOD

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

(2008) Jumei Shi et al.   BRITISH JOURNAL OF HAEMATOLOGY